Loading...

PhilipJax's Recent CancerCompass Activity

  • PhilipJax has replied to a post on the message board

    Normal 0 false false false MicrosoftInternetExplorer4 Chemotherapy-First Better Than Surgery-First? Chemo Better For Those Initially Eligible For Surgery Everyone,           In my previous posting I failed to link Dr Martin’s article which favors metastasis removal when they are few in one organ (o...

    April 08 at 3:15 AM view post
    • PhilipJax has replied to a post on the message board

      Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 Metastases Removal May Become Accepted Practice Advantage For Patients with<3 Metastases in 1 Organ Everyone,           Surg...

      April 07 at 2:26 AM view post
      • PhilipJax has replied to a post on the message board

        Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 Cisplatin & Cytotoxic Agent Harshness In the Context of Life & Death Everyone           It is correct that many cytotoxi...

        April 04 at 1:55 PM view post
        • PhilipJax has replied to a post on the message board

          Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; ...

          April 02 at 1:44 AM view post
          • PhilipJax has replied to a post on the message board

            Normal 0 false false false MicrosoftInternetExplorer4 IRE + Chemotherapy Trial Robert CG Martin, U of Louisville Everyone,           Yesterday, the University of Louisville announced a clinical trial to evaluate “the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitab...

            March 31 at 11:38 AM view post
            • PhilipJax has replied to a post on the message board

              Normal 0 false false false MicrosoftInternetExplorer4 Third-Line Therapy More on Erlotinib + Gemcitabine Everyone:           New research, published February 2018, gives credulity to Erlotinib + Gemcitabine as a useful Third-Line Therapy, if the patient develops a rash.  The research, conducted at 2...

              March 30 at 3:15 AM view post
              • PhilipJax has replied to a post on the message board

                Normal 0 false false false MicrosoftInternetExplorer4 st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in...

                March 23 at 1:55 AM view post
                • PhilipJax has replied to a post on the message board

                  Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 Dear CASDAD,           Go to the NCCN website and complete the free user registration.  Then search among the “profess...

                  March 13 at 3:30 PM view post
                  • PhilipJax has replied to a post on the message board

                    Normal 0 false false false MicrosoftInternetExplorer4 st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in...

                    March 05 at 8:52 PM view post
                    • PhilipJax has replied to a post on the message board

                      Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; ...

                      March 03 at 2:32 PM view post
                      Loading...
                      Load more activity
                      Loading more activity

                      About PhilipJax

                      PhilipJax has not shared any information about themselves. Send them a message to tell them you'd like to find out more about them or add them as a friend.

                      We care about your feedback. Let us know how we can improve your CancerCompass experience.